Bispecific antiCD3 x antiHER2 antibody mediates T cell cytolytic activity to HER2positive colorectal cancer in vitro and in vivo

Publisher： Spandidos Publications

E-ISSN： 1791-2423|45|6|2446-2454

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.45, Iss.6, 2014-01, pp. : 2446-2454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-CD3 x EGFR bispecific antibody redirects cytokine-induced killer cells to glioblastoma in vitro and in vivo

By                    

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2567-2575

Spandidos Publications

Access to resources Recommend Favorite

Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis

By Drucker Aaron  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 347-354

Springer Publishing Company

Access to resources Recommend Favorite

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

By Latif Z.   Watters A.D.   Dunn I.   Grigor K.   Underwood M.A.   Bartlett J.M.S.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 56-63

Elsevier

Access to resources Recommend Favorite

Mechanism of action of anti-HER2 monoclonal antibodies

By Baselga J.   Albanell J.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 35-41

Springer Publishing Company

Access to resources Recommend Favorite

Fully human HER2/cluster of differentiation 3 bispecific antibody triggers potent and specific cytotoxicity of T lymphocytes against breast cancer

By Zhou Yan   Gou LanTu   Guo ZhiHui   Liu HaiRong   Wang JiangMan   Zhou ShuXian   Yang JinLiang   Li XiaoAn  

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-07 ,pp. : 147-154

Spandidos Publications

Access to resources Recommend Favorite